Insight Molecular Diagnostics (IMDX) Income from Continuing Operations (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Income from Continuing Operations of 11242000.0 for Q1 2026, up 52.69% sequentially from 23764000.0 in Q4 2025, and down 43.72% YoY from 19976129.94 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Income from Continuing Operations for 12 years, with the latest figure at 11242000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 43.72% year-over-year to 11242000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51090000.0 (up 8.45% YoY) and the FY2025 annual result came in at 59661000.0, up 52.45% from the prior year.
- Income from Continuing Operations rose to 11242000.0 in Q1 2026 per IMDX's latest filing, from 23764000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 5959000.0 in Q1 2023 and troughed at 33906000.0 in Q4 2024.
- A 5-year average of 9382000.0 and a median of 8333000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 274.6% in 2023, down 510.92% in 2023.
- Over 5 years, Income from Continuing Operations stood at 12017000.0 in 2022, then slumped by 33.08% to 15992000.0 in 2023, then sank by 112.02% to 33906000.0 in 2024, then increased by 29.91% to 23764000.0 in 2025, then surged by 52.69% to 11242000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 11242000.0, 23764000.0, and 7654000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.40 Mn |
| Mar 31, 2026 | -9.09 Mn |
| Dec 31, 2025 | -12.89 Mn |
| Sep 30, 2025 | -11.05 Mn |
| Jun 30, 2025 | -9.84 Mn |
| Mar 31, 2025 | -6.80 Mn |
| Dec 31, 2024 | -20.89 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -4.95 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -15.99 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | 5.96 Mn |
| Dec 31, 2022 | -12.02 Mn |
| Sep 30, 2022 | -1.82 Mn |
| Jun 30, 2022 | -1.36 Mn |
| Mar 31, 2022 | -3.41 Mn |
| Dec 31, 2021 | -35.69 Mn |
| Sep 30, 2021 | -13.80 Mn |